Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia.
von Bubnoff
N
N
Sandherr
M
M
Schlimok
G
G
Andreesen
R
R
Peschel
C
C
Duyster
J
J
D000368:Aged; D001752:Blast Crisis / Q000097:blood; D002908:Chronic Disease; D004802:Eosinophilia / Q000097:blood / Q000150:complications* / Q000473:pathology; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009196:Myeloproliferative Disorders / Q000097:blood / Q000150:complications* / Q000473:pathology; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D010976:Platelet Count; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics*; D039221:mRNA Cleavage and Polyadenylation Factors / Q000235:genetics*
D015514:Oncogene Proteins, Fusion; D039221:mRNA Cleavage and Polyadenylation Factors; C479819:FIP1L1-PDGFRA fusion protein, human; D020796:Receptor, Platelet-Derived Growth Factor alpha